Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis

The optimal antithrombotic regimen for patients with atrial fibrillation and ischemic heart disease remains unclear. Therefore, we aimed to compare the efficacy and safety of triple therapy (TT [an anticoagulant and 2 antiplatelet drugs]) with dual therapy (DAPT [2 antiplatelet drugs] or DT [an anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wengen, Guo, Linjuan, Liu, Fadi, Wan, Rong, Shen, Yang, Lip, Gregory Y.H., Hong, Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655270/
https://www.ncbi.nlm.nih.gov/pubmed/29113375
http://dx.doi.org/10.18632/oncotarget.20870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655270/
https://www.ncbi.nlm.nih.gov/pubmed/29113375
http://dx.doi.org/10.18632/oncotarget.20870

Ejemplares similares